PFNA vs Dual Mobility in Treatment of Unstable Trochanteric Fractures

NCT ID: NCT05677191

Last Updated: 2023-01-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-01

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Proximal femoral nail \[PFNA\] versus dual mobility arthroplasty in treatment of unstable trochanteric fractures

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

compare clinial outcome between two different procdures either using pfna or arthroplasty in the treatment of unstable trochaneric fractures

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Trochanteric Fractures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

proximal femoral nail

20 patient with trochanteric fractures , unstable type will use proximal femoral nail

Group Type EXPERIMENTAL

Proximal Femoral Nail

Intervention Type DEVICE

open reduction

Dual Mobility Arthroplasty

20 patient with trochanteric fractures , unstable type will use dual mobility arthroplasty

Group Type ACTIVE_COMPARATOR

Dual Mobility Arthroplasty

Intervention Type COMBINATION_PRODUCT

Hip Arthroplasty Surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Proximal Femoral Nail

open reduction

Intervention Type DEVICE

Dual Mobility Arthroplasty

Hip Arthroplasty Surgery

Intervention Type COMBINATION_PRODUCT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

PFNA THA

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients with trochanteric unstable fractures.
* age 60 or above
* recent fracture time within 2 weeks time period
* trochanteric starting point in pfna
* patients medical condition is stable

Exclusion Criteria

* stable trochanteric fractures
* delayed or neglected fractures
* unstable patients medical conditions
* pirformis fossa starting point in pfna
Minimum Eligible Age

60 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marcos Hanna Morris

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marcos Ha Morris

Role: CONTACT

1287076751 ext. 0020

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Orthopedic

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.